columvi
roche registration gmbh - glofitamab - lymphoma, large b-cell, diffuse - antineoplastiset aineet - columvi as monotherapy is indicated for the treatment of adult patients with relapsed or refractory diffuse large b cell lymphoma (dlbcl), after two or more lines of systemic therapy.
lamostad 5 mg dispergoituva tabletti
desitin arzneimittel gmbh - lamotriginum - dispergoituva tabletti - 5 mg - lamotrigiini
lamostad 25 mg dispergoituva tabletti
desitin arzneimittel gmbh - lamotriginum - dispergoituva tabletti - 25 mg - lamotrigiini
lamostad 50 mg dispergoituva tabletti
desitin arzneimittel gmbh - lamotriginum - dispergoituva tabletti - 50 mg - lamotrigiini
lamostad 100 mg dispergoituva tabletti
desitin arzneimittel gmbh - lamotriginum - dispergoituva tabletti - 100 mg - lamotrigiini
lamostad 200 mg dispergoituva tabletti
desitin arzneimittel gmbh - lamotriginum - dispergoituva tabletti - 200 mg - lamotrigiini
teglutik 5 mg/ml oraalisuspensio
italfarmaco sa - riluzole - oraalisuspensio - 5 mg/ml - rilutsoli
glavamin infuusioneste, liuos
fresenius kabi ab fresenius kabi ab - acidum glutamicum,acidum asparticum,lysini acetas,phenylalaninum,isoleucinum,histidinum,prolinum,leucinum,glycylglutaminum monohydricum,valinum,serinum,argininum,methioninum,threoninum,tryptophanum,alaninum,glycyltyrosinum dihydricum - infuusioneste, liuos - aminohapot
ketaminol vet 50 mg/ml injektioneste, liuos
intervet international b.v. - ketamine hydrochloride - injektioneste, liuos - 50 mg/ml - ketamiini
equest vet 18.92 mg/g oraaligeeli
zoetis animal health aps - moxidectine - oraaligeeli - 18.92 mg/g - moksidektiini